Hypertriglyceridemia and cardiovascular disease management

J Am Acad Nurse Pract. 2007;19(12 Suppl 2):7-10, 13-4.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Clofibric Acid / therapeutic use
  • Disease Management*
  • Fatty Acids, Omega-3 / therapeutic use
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / complications
  • Hypertriglyceridemia / diagnosis
  • Hypertriglyceridemia / prevention & control*
  • Hypolipidemic Agents / therapeutic use
  • Male
  • Middle Aged
  • Niacin / therapeutic use
  • Nurse Practitioners
  • Practice Guidelines as Topic
  • Primary Health Care / methods*
  • Risk Factors
  • Risk Reduction Behavior

Substances

  • Fatty Acids, Omega-3
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Niacin
  • Clofibric Acid